Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 30, Issue 4, 2001, Pages 229-234

  Feuerherm, A J ^a   Borset M ^a   Seidel, C ^a   Sundan, A ^a   Leistad, L ^a   Ostensen M ^a   Faxvaag, A ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

C met; Chondrocytes; Hepatocyte growth factor; Human articular cartilage; Osteoporosis; Osteoprotegerin

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE ATROPHY; BONE METABOLISM; CARTILAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HOMEOSTASIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SEROLOGY; SYNOVIAL FLUID LEVEL; SYNOVIUM;

ADULT; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID;

EID: 17944361818     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401316909585     Document Type: Article

References (33)

1. Rheumatoid arthritis. Epidemiology, etiology, rheumatoid factor, pathology pathogenesis
2. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey
3. The hand radiograph as a diagnostic discriminant between seropositive and seronegative "rheumatoid arthritis": A controlled study
4. Relationship of rheumatoid factor isotype levels with joint lesions detected by magnetic resonance imaging in early rheumatoid arthritis
5. Osteoporosis in patients with rheumatoid arthritis: Tip of the iceberg?
6. Radiology of seronegative Spondylarthropathies
7. Bone mass measurement and bone metabolism in rheumatoid arthritis: A review
8. Osteoporosis, body composition, and bone turn-over in ankylosing spondylitis
9. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis
10. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
11. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
12. Involvement of receptor activator of nuclear factor -κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
13. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
14. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
15. Osteoprotegerin is a cytokine that regulates osteoclast differentiation and activation
16. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
17. Modulation of osteoclast differentiation and function by the new members of the turnout necrosis factor receptor and ligand families
18. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
19. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
20. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration
21. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
22. The effect on hepatocyte growth factor on the behaviour of osteoclasts
23. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis
24. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/Osteoprotegerin
25. Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines
26. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells
27. Transforming growth factor-betal increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast like cells
28. Levels of human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay
29. Hepatocyte Growth Factor. A cytokine mediating endothelial migration in inflammatory arthritis
30. Role of hepatocyte growth factor and its receptor c-met in multiple myeloma
31. Levels of Hepatocyte Growth Factor in synovial fluid and serum of patients with Rheumatoid Arthritis and release of Hepatocyte Growth Factor by Rheumatoid Synovial Fluid Cells
32. Hepatocyte growth factor in human osteoarthritic cartilage
33. Cellular mechanisms of development